New Leaf DAO
New Leaf is a decentralized investment platform unlocking the potential of medicinal cannabis markets. By tokenizing premium real-world cannabis assets, it drives strategic investment, boosts industry efficiency with blockchain and AI, and democratizes access for patients, clinicians, investors, and regulators. Backed by experts in cannabis, global finance, and blockchain, New Leaf aligns strong market demand with scalable, transparent growth.
$4.1 Billion
Projected pre-roll cannabis sales in 2024, reflecting rapid market adoption.
15.9%
Market share growth of pre-roll products in 2024, driven by rising patient demand and expanding legalization.
$1.75 Billion
Revenue generated by infused pre-rolls combining flower with concentrates in 2024.
Cannabis science is booming, but research is fragmented and slow. We fund open studies, accelerate validation, and turn insights into community-owned assets.
Additional documentation
The global medical cannabis market presents a multi-billion-euro opportunity, driven by legalization, patient demand, and new therapeutic applications....
Phytochemical Profiling of New Leaf’s Medicinal Cannabis Strains
This study aims to chemically analyze New Leaf’s existing portfolio of proprietary medical cannabis strains to identify and characterize their cannabinoid, terpene, and flavonoid compositions. This foundational research will support the development of targeted, standardized formulations for therapeutic use, particularly in the treatment of pain-related conditions such as migraine and headache.
Evaluating the Efficacy of a Proprietary Cannabis Strain for Pain Relief
Following the comprehensive chemical profiling of New Leaf’s proprietary medical cannabis strains, this study aims to evaluate the analgesic potential of a selected strain shown to exhibit a unique and synergistic profile of cannabinoids, terpenes, and flavonoids.
Evaluating a Proprietary Cannabis Strain for Symptom Relief in Parkinson’s Disease
Building on the chemical profiling of New Leaf’s proprietary medical cannabis strains, this study aims to assess the therapeutic potential of a specific strain identified for its neuroprotective and anti-inflammatory properties in alleviating symptoms of Parkinson’s disease (PD).
＠newleaf_finance on 𝕏
Discord community
Telegram community
By tokenizing real-world, premium cannabis assets, New Leaf benefits all stakeholders—patients, clinicians, investors, and regulators—while democratizing access to the industry. At token launch, investors gain exposure to US$25M in enterprise value a...
Frontiers in Pharmacology
Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis
Headache
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Journal of Pain and Symptom Management
